Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alexandria Research Technologies (ART) was a medical device company specializing in innovative orthopaedic solutions for knee replacement. Founded by Dr. Gerard Engh and Wesley Johnson, the company developed the "Tissue Guided Surgery" (TGS) platform, which aimed to optimize implant placement based on a patient's unique knee kinematics. Their primary products included the MIRROR Partial Knee System and the TGOS Unicompartmental Knee Arthroplasty system, both of which received FDA clearance. Headquartered in Plymouth, Minnesota, the company focused on minimally invasive techniques to restore knee function in patients with osteoarthritis. Although the company is currently inactive, its technologies contributed significantly to the field of patient-specific orthopaedic surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alexandra Research Technologies.